Evelo Therapeutics (Series A)

Funding Details
Awarder
Inbox
Date Award
November 04, 2015
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$35,000,000

Company Info
Founding Year
2015
Founders
Simba Gill
Company Description
Evelo Therapeutics is dedicated to transforming cancer therapy through a deep understanding of the cancer microbiome. Evelo is discovering and developing Oncobioticâ„¢ therapies, novel treatments designed to attack cancer by disrupting the microbial environment which supports tumors and protects them from the body's immune system.
Market
Cancer Therapy
Location
Cambridge, MA, USA

Links